Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Cytomx Thera Cmn Stk (CTMX)

14.80 +0.41 (+2.85%)

6/23/2017  4:00pm

Open:

14.36

Pre. Close:

14.39

High:

14.97

Low:

14.12

Volume:

1,262,526

Market Cap:

543.89M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.29 - 15.45

15.45 - 15.6

Low:

13.4 - 13.54

13.54 - 13.68

Close:

14.29 - 14.7

14.7 - 15.12

Technical analysis  (as of: 2017-06-23 4:33:29 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 17.72     One year: 20.70

Support:

Support1: 13.86    Support2: 13.05

Resistance:

Resistance1: 15.17    Resistance2: 17.72

Pivot:

13.93

Moving Averages:

MA(5): 14.28     MA(20): 14.05

MA(100): 14.56     MA(250): 12.99

MACD:

MACD(12,26): -0.16     Signal(12,26,9): -0.32

%K %D:

%K(14,3): 73.50     %D(3): 60.22

RSI:

RSI(14): 56.46

52-Week:

High: 20.02  Low: 9.10  Change(%): 53.5

Average Vol(K):

3-Month: 230  10-Days 361

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CTMX has closed above the upper band by 2.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 36.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 01 Sep 2015 09:09:58 GMT
14.80

Fri, 23 Jun 2017 21:30:07 GMT
CytomX Therapeutics Inc. (CTMX) Moves Higher on Volume Spike for June 23

Mon, 15 May 2017 19:52:30 GMT
CytomX Announces Management Team Changes

Sat, 24 Jun 2017 02:15:00 GMT
Bargain or Bust? What's inside the Numbers For CytomX Therapeutics, Inc ...

Thu, 03 Nov 2016 20:03:45 GMT
CytomX Therapeutics Announces Third Quarter 2016 Financial Results and ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

36.75

Shares Float (M)

20.89

% Held by Insiders

% Held by Institutions

Shares Short (K)

774

Shares Short Prior Month (K)

715

Stock Financials

EPS

-1.410

EPS Est. Current Year

-1.460

EPS Est. Next Year

-1.130

EPS Est. Next Quarter

-0.370

Forward EPS

-1.130

Book Value (p.s.)

2.010

PEG Ratio

-1.85

Profit Margin

-208.92

Operating Margin

-212.55

Return on Assets (ttm)

-17.6

Return on Equity (ttm)

-54.8

Qtrly Rev. Growth

424.2

Gross Profit (p.s.)

0.409

Sales Per Share

EBITDA (p.s.)

-1.367

Qtrly Earnings Growth

Operating Cash Flow (M)

-15.58

Levered Free Cash Flow (M)

-4.37

FoxReading.com

Valuation

P/E

-10.50

P/E Growth Ratio

0.03

P/BV

7.36

P/S

811791104.00

P/CF

-34.91

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-01-03

Ex-Dividend Date

2017-11-05

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.